Los Angeles Capital Management’s Akebia Therapeutics AKBA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $97.3K | Buy |
26,743
+70
| +0.3% | +$255 | ﹤0.01% | 1254 |
|
|
2025
Q1 | $51.2K | Buy |
+26,673
| New | +$51.2K | ﹤0.01% | 1075 |
|
|
2020
Q4 | – | Sell |
-26,550
| Closed | -$67K | – | 1505 |
|
|
2020
Q3 | $67K | Buy |
26,550
+12,310
| +86% | +$31.1K | ﹤0.01% | 1423 |
|
|
2020
Q2 | $193K | Buy |
+14,240
| New | +$193K | ﹤0.01% | 1402 |
|
|
2018
Q4 | – | Sell |
-33,655
| Closed | -$297K | – | 1262 |
|
|
2018
Q3 | $297K | Sell |
33,655
-136,070
| -80% | -$1.2M | ﹤0.01% | 1226 |
|
|
2018
Q2 | $1.69M | Buy |
169,725
+103,920
| +158% | +$1.04M | 0.01% | 740 |
|
|
2018
Q1 | $627K | Buy |
65,805
+7,925
| +14% | +$75.5K | ﹤0.01% | 964 |
|
|
2017
Q4 | $861K | Buy |
57,880
+4,840
| +9% | +$72K | ﹤0.01% | 891 |
|
|
2017
Q3 | $1.04M | Buy |
+53,040
| New | +$1.04M | 0.01% | 807 |
|